American Green Stock Fundamentals

ERBB Stock  USD 0.0006  0.0001  20.00%   
American Green fundamentals help investors to digest information that contributes to American Green's financial success or failures. It also enables traders to predict the movement of American Pink Sheet. The fundamental analysis module provides a way to measure American Green's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to American Green pink sheet.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

American Green Company Price To Sales Analysis

American Green's Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.

P/S

 = 

MV Per Share

Revenue Per Share

More About Price To Sales | All Equity Analysis

Current American Green Price To Sales

    
  736.84 X  
Most of American Green's fundamental indicators, such as Price To Sales, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, American Green is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.
Competition

Based on the latest financial disclosure, American Green has a Price To Sales of 736 times. This is much higher than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—Specialty & Generic industry. The price to sales for all United States stocks is notably lower than that of the firm.

American Green Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining American Green's current stock value. Our valuation model uses many indicators to compare American Green value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across American Green competition to find correlations between indicators driving American Green's intrinsic value. More Info.
American Green is one of the top stocks in operating margin category among its peers. It is rated # 4 in current valuation category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value American Green by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for American Green's Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.

American Price To Sales Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses American Green's direct or indirect competition against its Price To Sales to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of American Green could also be used in its relative valuation, which is a method of valuing American Green by comparing valuation metrics of similar companies.
American Green is currently under evaluation in price to sales category among its peers.

American Fundamentals

About American Green Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze American Green's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of American Green using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of American Green based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
American Green, Inc. operates as a technology company in the medical cannabis industry in the United States. The company was formerly known as Tranzbyte Corporation and changed its name to American Green, Inc. in May 2014. American Green is traded on OTC Exchange in the United States.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in American Pink Sheet

American Green financial ratios help investors to determine whether American Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in American with respect to the benefits of owning American Green security.